Improving Outcomes for Advanced Prostate Cancer
Podcasts:
Use of immunotherapy in Medicare patients with advanced prostate cancer
Presented by: Rana R. McKay, MD
Rana McKay, MD, discusses a study utilizing Medicare claims data from more than 6,000 mCRPC patients who had been treated with Provenge, oral medications, or both. She highlights key findings, including reduced risk of death and extended median overall survival.
Rana R. McKay, MD, is a board-certified medical oncologist who specializes in treating people with genitourinary (urologic) cancers, including bladder cancer, kidney cancer, prostate cancer and testicular cancer. As a clinical investigator, she is committed to advancements in cancer care that will improve the lives of patients.
Improving Outcomes for Advanced Prostate Cancer
Presented by: Taylor Bragg, MD
Dr. Bragg attended Birmingham-Southern College where he earned a Bachelor of Science degree in 1984. He received his medical education at the University Alabama at Birmingham School of Medicine. Following graduation from medical school he completed two years of general surgery residency and three years of urological residency at the UAB Hospital. He joined Eastern Urology Associates in 1993.
Besides being a partner of Urology Centers of Alabama, Dr. Bragg has been the president of the Birmingham Urology Club, chairman of the Department of Surgery at St. Vincent’s East, and a member of the Birmingham Surgical Society.
Dr. Bragg is certified in urology by the American Board of Urology. He is a member of the American Urological Association, the American Medical Association, the Medical Association of the State of Alabama, the Jefferson County Medical Society, and the Birmingham Urology Club. He is a member of the medical staff at St. Vincent’s East, Brookwood Medical Center and Trinity Medical Center. Dr. Bragg is from Birmingham, Alabama.
Demystifying Vector-Based Intravesical Gene Therapy for NMIBC: A New Frontier
November 28th 2023Neal Shore, MD, FACS, is a U.S. Chief Medical Officer at GenesisCare USA and Medical Director of the Carolina Urologic Research Center. He also was an investigator on the Phase 2 and 3 studies in the clinical trial program for nadofaragene firadenovec-vncg.
The Evolution of Single-Use Urologic Endoscopy
October 21st 2021Dr. Michael Lipkin discusses a recent study conducted at Duke University Hospital that found that a new single-use cystoscope demonstrated superior flexion and comparable optics to the reusable scopes already being used in a hospital urology department.
